Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.

Gureev, Artem P; Popov, Vasily N

Gureev, Artem P; Popov, Vasily N.

Affiliation

Gureev AP; Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia. gureev@bio.vsu.ru.
Popov VN; Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.

Neurochem Res ; 44(10): 2273-2279, 2019 Oct.

Article in En | MEDLINE | ID: mdl-30617864

Subject(s)

Mitochondria/metabolism; Mitophagy/physiology; NF-E2-Related Factor 2/metabolism; Parkinson Disease/therapy; Animals; Dopaminergic Neurons/drug effects; Dopaminergic Neurons/metabolism; Humans; Mitochondria/drug effects; Mitophagy/drug effects; NF-E2-Related Factor 2/drug effects; Parkinson Disease/metabolism; Signal Transduction/drug effects; Ubiquitin-Protein Ligases/drug effects; Ubiquitin-Protein Ligases/metabolism

Key words

Mitochondrial biogenesis; Mitochondrial quality control; Mitophagy; Nrf2; Parkinson disease

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / NF-E2-Related Factor 2 / Mitophagy / Mitochondria Limits: Animals / Humans Language: En Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google